TRIM24 Is an Oncogenic Transcriptional Activator in Prostate Cancer

被引：203

作者：

Groner, Anna C. ^{[1
,2
]}

Cato, Laura ^{[1
,2
]}

de Tribolet-Hardy, Jonas ^{[1
,2
]}

Bernasocchi, Tiziano ^{[3
]}

Janouskova, Hana ^{[3
]}

Melchers, Diana ^{[4
]}

Houtman, Rene ^{[4
]}

Cato, Andrew C. B. ^{[5
]}

Tschopp, Patrick ^{[6
]}

Gu, Lei ^{[7
,8
]}

Corsinotti, Andrea ^{[9
,10
]}

Zhong, Qing ^{[11
]}

Fankhauser, Christian ^{[11
,12
]}

Fritz, Christine ^{[11
]}

Poyet, Cedric ^{[12
]}

Wagner, Ulrich ^{[11
]}

Guo, Tiannan ^{[13
]}

Aebersold, Ruedi ^{[13
,14
]}

Garraway, Levi A. ^{[1
,15
,16
]}

Wild, Peter J. ^{[11
]}

Theurillat, Jean-Philippe ^{[3
,15
,17
]}

Brown, Myles ^{[1
,2
]}

机构：

[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA

[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Ctr Funct Canc Epigenet, 44 Binney St, Boston, MA 02115 USA

[3] Inst Oncol Res, CH-6500 Bellinzona, Switzerland

[4] PamGene Int, NL-5211 HH Den Bosch, Netherlands

[5] Karlsruhe Inst Technol, Inst Toxicol & Genet, D-76344 Eggenstein Leopoldshafen, Germany

[6] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02215 USA

[7] Harvard Univ, Sch Med, Childrens Hosp Boston, Div Newborn Med, Boston, MA 02215 USA

[8] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02215 USA

[9] Univ Edinburgh, Sch Biol Sci, Inst Stem Cell Res, MRC Ctr Regenerat Med, Edinburgh EH16 4UU, Midlothian, Scotland

[10] Univ Tsukuba, Fac Med, Dept Anat & Embryol, Lab Anim Resource Ctr, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan

[11] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland

[12] Univ Zurich Hosp, Dept Urol, CH-8091 Zurich, Switzerland

[13] ETH, Inst Mol Syst Biol, Dept Biol, CH-8093 Zurich, Switzerland

[14] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland

[15] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA

[16] Harvard Univ, Sch Med, Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA

[17] Univ Lausanne, CHU Vaudois, CH-1011 Lausanne, Switzerland

来源：

CANCER CELL | 2016年 / 29卷 / 06期

基金：

瑞士国家科学基金会;

关键词：

ANDROGEN-RECEPTOR GENE; MUTATIONAL LANDSCAPE; SPOP; PROGRESSION; EXPRESSION; COACTIVATOR; RECURRENCE; MECHANISM; CELLS; MODEL;

D O I：

10.1016/j.ccell.2016.04.012

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Androgen receptor (AR) signaling is a key driver of prostate cancer (PC). While androgen-deprivation therapy is transiently effective in advanced disease, tumors often progress to a lethal castration-resistant state (CRPC). We show that recurrent PC-driver mutations in speckle-type POZ protein (SPOP) stabilize the TRIM24 protein, which promotes proliferation under low androgen conditions. TRIM24 augments AR signaling, and AR and TRIM24 co-activated genes are significantly upregulated in CRPC. Expression of TRIM24 protein increases from primary PC to CRPC, and both TRIM24 protein levels and the AR/TRIM24 gene signature predict disease recurrence. Analyses in CRPC cells reveal that the TRIM24 bromodomain and the AR-interacting motif are essential to support proliferation. These data provide a rationale for therapeutic TRIM24 targeting in SPOP mutant and CRPC patients.

引用

页码：846 / 858

页数：13

共 50 条

[1] TRIM24 is an oncogenic transcriptional activator in prostate cancer
Groner, Anna C.
Cato, Laura
de Tribolet-Hardy, Jonas
Bernasocchi, Tiziano
Zhong, Qing
Fankhauser, Christian
Fritz, Christine
Poyet, Cedric
Wagner, Ulrich
Garraway, Levi A.
Wild, Peter J.
Theurillat, Jean-Philippe
Brown, Myles
CANCER RESEARCH, 2016, 76
[2] TRIM24 acts as a transcriptional activator
Louise Stone
Nature Reviews Urology, 2016, 13 (8) : 437 - 437
[3] TRIM24 IS AN ONCOGENIC TRANSCRIPTIONAL CO-ACTIVATOR OF STAT3 IN GLIOBLASTOMA
Feng, Haizhong
Jiao, Shanghai
NEURO-ONCOLOGY, 2018, 20 : 53 - 53
[4] TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma
Deguan Lv
Yanxin Li
Weiwei Zhang
Angel A. Alvarez
Lina Song
Jianming Tang
Wei-Qiang Gao
Bo Hu
Shi-Yuan Cheng
Haizhong Feng
Nature Communications, 8
[5] TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma
Lv, Deguan
Li, Yanxin
Zhang, Weiwei
Alvarez, Angel A.
Tang, Jianming
Hu, Bo
Cheng, Shi-Yuan
Feng, Haizhong
CANCER RESEARCH, 2018, 78 (13)
[6] TRIM24 is an oncogenic transcriptional co-activator of STAT3 in glioblastoma
Lv, Deguan
Li, Yanxin
Zhang, Weiwei
Alvarez, Angel A.
Song, Lina
Tang, Jianming
Gao, Wei-Qiang
Hu, Bo
Cheng, Shi-Yuan
Feng, Haizhong
NATURE COMMUNICATIONS, 2017, 8
[7] TRIM24 acts as a transcriptional co-activator of the androgen receptor during prostate cancer progression
Groner, Anna C.
de Tribolet-Hardy, Jonas
Theurillat, Jean-Philippe
Wild, Peter J.
Brown, Myles
CANCER RESEARCH, 2015, 75
[8] TRIM24 as an independent prognostic biomarker for prostate cancer
Offermann, Anne
Roth, Doris
Hupe, Marie Christine
Hohensteiner, Silke
Becker, Finn
Joerg, Vincent
Carlsson, Jessica
Kuempers, Christiane
Ribbat-Idel, Julika
Tharun, Lars
Sailer, Verena
Kirfel, Jutta
Svensson, Maria
Andren, Ove
Lubczyk, Verena
Kuefer, Rainer
Merseburger, Axel S.
Perner, Sven
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (09) : 576.e1 - 576.e10
[9] TRIM24 as Independent Prognostic Marker in Prostate Cancer
Offermann, Anne
Schneider, Felix
Hupe, Marie Christine
Hohensteiner, Silke
Becker, Finn
Carlsson, Jessica
Kirfel, Jutta
Svensson, Maria
Andren, Ove
Merseburger, Axel
Lubczyk, Verena
Kuefer, Rainer
Sven, Perner
LABORATORY INVESTIGATION, 2018, 98 : 372 - 373
[10] TRIM24 as Independent Prognostic Marker in Prostate Cancer
Offermann, Anne
Schneider, Felix
Hupe, Marie Christine
Hohensteiner, Silke
Becker, Finn
Carlsson, Jessica
Kirfel, Jutta
Svensson, Maria
Andren, Ove
Merseburger, Axel
Lubczyk, Verena
Kuefer, Rainer
Sven, Perner
MODERN PATHOLOGY, 2018, 31 : 372 - 373

← 1 2 3 4 5 →